1) acute myeloid leukemia(AML)/old
急性髓性白血病/老年
2) elderly acute myeloid leukemia
老年急性髓系白血病
1.
Curative effect analysis of HAG plan treating elderly acute myeloid leukemia
HAG方案治疗老年急性髓系白血病16例疗效分析
4) acute myeloid leukemia
急性髓性白血病
1.
IFN-alpha promotes the full maturation of dendritic cells derived from acute myeloid leukemia cells in vitro;
α干扰素促进急性髓性白血病来源的树突状细胞的成熟分化
2.
Expression of CD19, CD56 and CD2 in acute myeloid leukemia;
CD19、CD56、CD2在急性髓性白血病的表达
3.
Treating acute myeloid leukemia with Delisheng injection combined with chemotherapy;
得力生联合化疗治疗急性髓性白血病疗效观察
5) Acute myelogenous leukemia
急性髓性白血病
1.
To investigate the effect of rhIL-11 combined with HAM regimen on acute myelogenous leukemia (AML).
[目的]研究重组白介素11(rhIL鄄11)联合HAM方案化疗对急性髓性白血病的疗效。
6) AML
急性髓性白血病
1.
The Gene Expression and It s Clinical Significance of Breast Cancer Resistance Protein(BCRP) in Patients with Acute Non-lymphocytic Leukemia(AML);
乳腺癌耐药蛋白在急性髓性白血病中的表达和临床意义
2.
Methods: The level of sICAM-1 in ALL group(n=20),AML group(n=27) and the control group(n=20) was measured by ELISA.
方法:ELISA法对20例正常健康人及20例急性淋巴细胞白血病(ALL)、27例急性髓性白血病(AML)化疗前后血清sICAM-1水平进行检测。
3.
Objective: To study the correlation of multidrug resistance protein P170 and active T cell in acute myeloblatlic leukemia(AML).
研究目的：探讨急性髓性白血病耐药蛋白P_(170)与活化T细胞的关系。
补充资料：急性单核细胞性白血病
急性单核细胞性白血病
参见"急性白血病"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条